Titlebook: Antibody-Drug Conjugates; The 21st Century Mag Jeffrey Wang,Wei-Chiang Shen,Jennica L. Zaro Book 2015 American Association of Pharmaceutica

AV-node

Selecting an Optimal Antibody for Antibody- Drug Conjugate Therapygy indications. ADC-based therapies are attractive due to their potential to increase efficacy and reduce the systemic toxicity produced by other conventional anticancer regimens. ADCs are complex molecules, however, and their clinical success depends both on properties of the target in the context

休戰(zhàn)